GABAergic system in action: connection to gastrointestinal stress-related disorders.

Abstract

BACKGROUND Currently, treatment of stress-related gastrointestinal disorders, such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), is mainly symptomatic since there is no drug on the market that solves effectively diverse disease symptoms and comorbid states. Thus, recently GABA receptors have been identified within gastrointestinal system and it has been recognized that among various GABAergic drugs some of them influence gastrointestinal stress-related diseases. Firstly, benzodiazepines have been investigated due to their diverse effects: neuroimmunomodulatory, relief of visceral pain and anxiolytic action. CONCLUSION The present review brings findings on the expression of GABA receptors in the gastrointestinal tract and the role of GABA within it. We also present knowledge on the role of neurotransmitter GABA and various GABAergic ligands on diverse physiologic gastrointestinal functions with special emphasize to stress-related disorders. The rationale for therapeutic use and further identification of a potential GABAergic treatment of stress-related disorders has been critically discussed.

DOI: 10.2174/1381612823666170209155753

Statistics

050010002017
Citations per Year

98 Citations

Semantic Scholar estimates that this publication has 98 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Jembrek2017GABAergicSI, title={GABAergic system in action: connection to gastrointestinal stress-related disorders.}, author={Maja Jazvin{\vs}{\'c}ak Jembrek and Michelangelo Auteri and Rosa Serio and Josipa Vlaini{\'c}}, journal={Current pharmaceutical design}, year={2017} }